The Nigerian Journal of Clinical Pharmacy and Therapeutics (NJCPT) is a quarterly publication of the Clinical Pharmacists Association of Nigeria (CPAN). NJCPT will be published simultaneously in electronic. The journal website is https://njcpt.com.ng/
NJCPT will consider all manuscripts on the strict condition that they have not been previously published, nor are they submitted for consideration for publication or in press elsewhere in full or in part and that the work is an original work by the authors. Nigerian Journal of Clinical Pharmacy and Therapeutics publishes original research papers, review articles, systematic reviews and meta analyses, clinical trials, short communications in Clinical Pharmacy practice in all ramifications, Pharmaceutical care, Therapeutics, Alternative Medicine, Clinical Pharmacognosy, Medicines management, Pharmacoeconomics, Pharmacy Management, Public Health Pharmacy and Public Health in general, Pharmacology, Pharmaceutical Sciences
Toxicology, Technology and Biotechnology, Biomedical sciences and other aspects of pharmacy practice including hospital and administrative pharmacy, social pharmacy, community pharmacy, industrial pharmacy. NJCPT may also solicit and/or accept unrequested manuscripts which are conference reports, position papers, editorials and personal views from time to time.
Authors are expected to indicate the following in writing.
1.The work is original and has not been previously published elsewhere in full or part
2. No part of the work is presently undergoing review for publication by other publishers
NJCPT makes the following assumptions on receipt of a manuscript:
1. The final submitted manuscript has the endorsement of all the authors
2. Permission to use all copyright resources have been obtained prior to submission.
The manuscript should come as a single file including text, figures and tables. Figures and tables should be placed where they should appear in the manuscript. Legends should be included in the figures and tables. A cover letter should accompany each submission and should be addressed to:
Nigerian Journal of Clinical Pharmacy and Therapeutics
c/o Pharmacy House,
32, Faramobi Ajike Street,
Behind Idiroko Bus stop, Anthony,
Lagos, Nigeria.
Email: njcpt@njcpt.com.ng
Call: +234-905-788-9730
The corresponding author must indicate in the cover letter that the manuscript has not been previously published, nor is it currently under consideration for publication or in press elsewhere. The corresponding author must state that s/he is authorized to correspond with the Journal for all matters related to the manuscript on behalf of all other authors. The roles played by each author should be clearly indicated in the cover letter. For the purposes of NJCPT, authorship is constituted by: 1) Conception and design of the study or analysis and interpretation of data and/or 2) Drafting the paper or substantially revising it and/or 3) Approving the final version to be published and 4) Accepting accountability for all aspects of the work. Contributors that do not qualify for authorship should be appropriately recognized in the acknowledgement section. Finally, the corresponding author should declare all sources of conflict of interest on behalf of all authors, if any. In cases where there are conflicts. the corresponding author should clearly state the nature of the conflict(s) which may include but are not limited to source of funding, provision of drugs or equipment, position on the Management Board etc. If there are no conflicts of interest, a statement on this should be clearly made. The cover letter MUST be duly signed by the corresponding author.
* Acceptable format for all manuscripts is MS Word document written in Times New Roman with the font size of 12.
* The language of NJCPT is British English. Each manuscript should be typed double-spaced on A4 (8.5″ × 11″) paper size with 1-inch margins. Alignment should be justified.
* The maximum length of manuscripts should be 6000 words for review articles, 3000 words for research articles, 1,500 words for conference reports, position papers, technical notes, commentaries and short communications. Requirements for solicited articles will be dependent on the type of request made.
*The text of observational and experimental manuscripts should be divided into the following sections: Abstract, Keywords, Introduction, Methods (Materials and Methods for analytical work), Results, Discussion, Conclusion, Acknowledgements and References. Long articles may require subheadings within some sections (especially Results and Discussion) to clarify their content. Other types of articles, such as case reports, reviews and editorials, may need to be formatted differently.
Reviewers: The Editorial board may ask authors to make available prospective peer reviewers with their contact details and credentials for assessment of their choice without being duty bound to choose them or not.
Human Studies and Subjects: For all cases where human studies and subjects are used, informed consent of the individuals must be obtained for their participation and subsequent usage of related materials such as Images, videos etc of such a subject for publication materials. More so, institutional ethical approval must be obtained, and copy included in the manuscript.
Clinical Trial Registration: For all clinical trials, authors will be required to have registered and obtained a trial registration number from a clinical trials database registry and these details included after the abstract.
Privacy: For the purpose of manuscripts submission for reviewing, utmost confidentiality, security and integrity will be ensured as regards the personal details and information supplied by authors while the publisher goes about its business and services of production and publication.
1. Every part of the manuscript should appear on a separate page.
2. The first page should contain the following items: Title, Name of Author(s), Affiliations and running title of not more than fifty (50) characters with spaces. The title should normally not be more than twenty-five (25) words. The corresponding author should be indicated with an asterisk and full contact details (address, email and phone numbers) provided on the first page.
3. Abstract should be on the second page and should be structured, as follows: Background, Objectives, Methods (Materials and Methods for analytical work), Result and Conclusion. A maximum of six (6) keywords should be provided at the end of the abstract.
4. The introduction should provide a concise overview of literature pertinent for the study, its objectives and why the proposed study is relevant. The language and content should be suitable for international readership. The objectives of the study must be clearly stated at the end of the introduction
5. The methods (Materials and Methods) section should describe the methods used for the study in appropriate detail to enable replication of the study by interested researchers. This section should clearly state how data was coded (if applicable) and how all statistical analysis was carried out. It should also present ethical considerations applicable to the study.
6. The Results section should first summarize all the results in text before referring to tables and figures for details. Data should not be repeated in figures and tables nor in text and tables/charts. Only summaries should precede the tables/charts in prose. The position of the Tables or Charts presented in the article should be clearly indicated within the result text.
Tables: Tables should be provided close to where they should appear when printed. The content of each table should be complementary and not a duplicate of the text. Tables should be numbered with Arabic numerals. Each table should be typed using a table format (i.e., each variable must be typed into a separate cell in the table) with only horizontal lines above and below the table column headers and at the bottom of the table. The title should be typed at the top of the table in the sentence case format, i.e., only the first name should be in capital letters; names should also be in capital letters, as appropriate. Any legend should be typed at the top and bottom of the table in italics. Tables should only have top and bottom borders at the first row and a bottom border at the end of the table. No middle horizontal lines and no vertical lines whatsoever. Labels of tables MUST be in text form and MUST not be embedded in the table.
Figures: Figures should be professionally drawn electronically and inserted in the appropriate position where it is first cited within the text. If photographs of patients are used, either the subjects are not identifiable, or their pictures must be accompanied by a written permission to use the images. Photographs must be clear and sharp. Labels of figures/illustrations MUST be in text form and MUST not form part of the image.
7. The discussion section should summarize the main findings, interpret the findings and compare these finding with previous studies, as well as the contribution made to the field. A critique of the strengths and limitations of the research including any policy limitations can be provided here. The discussion section should not be used to repeat results already presented in the results section.
8. A brief conclusions section should summarize the salient findings of the study based on the study objectives. Unqualified statements and conclusions not adequately supported by the data generated should be avoided.
Acknowledgements: All those who contributed to the work but not sufficiently to qualify them for authorship should be listed in the acknowledgements section.
References can be typed single-spaced and numbered consecutively in the order in which they are cited in the text. Arabic numerals (superscript), e.g., (1, 1,3,5 or 1-4) should be used in citing references in the text. Index Medicus Style of abbreviations should be used for journals cited. For correct abbreviations visit http://www.ncbi. nlm.nih.gov/PubMed/jbrowser.html. Journals not abbreviated in this list should be written in full. Unpublished work should not be included in the list of references.
Sample references:
Articles
Standard Article: Becker A D, Harke AJ, Thomas G, John SE. Aspirin and Cardioprotection: Optimizing its beneficial effects. Annual of Internal Medicine. JK Institute. 1998; 2288:72-83.
Corporate Article: Global Burden of Diarrhoeal Diseases Collaborators. Estimates of global, regional and national morbidity, mortality and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis., 2017;17:909-948
Supplement: Ogbo PU, Aina BA and Obettah NC. Increasing burden of childhood obesity among children 5-11 years old in Lagos, Nigeria. Obes Rev., 2014;15(Supl 2):206-248.
Books and Monographs
Author: Rogers EM. Diffusion of Innovations 5th ed. NY Free Press; 2003 Editors: Kumar P, Clark M, eds. Clinical Medicine. 6th ed. NY. Elsevier Saunders, 2005.
Murray, P. Histological procedures in Pathology. Barminger: Springer-AD; 1998.
Chapter of a book: Swanson LN; Harrison TM: OTC Weight Control, Sleep, and Smoking Cessation Agents. In: Shargel L, Mutnick AH, Souney PF, Swanson LN, Eds. Comprehensive Pharmacy Review. Philadelphia: Lippincott Williams & Wilkins; 2001:543-555.
Work of a congress/Symposium/ International Meeting: Soremekun RO, Apanpa-Apanpa BN and Adeyemi OC. Patient and provider perceived factors influencing HAART access in rural Epe and Ikorodu LGAs, Lagos state. Presented at the 10th Annual UNILAG Research Conference and Fair, 24th-26th November 2015, Lagos Nigeria.
Internet
Books: American Safety and Health Institute. Basic First Aid for the Community and Workplace [Online]. American Safety and Health Institute 2008. Electronic version of the same name. https://co.grand.co.us/DocumentCenter/View/555/Basic-First-Aid-Student-Handbook [Accessed: 10th May 2016]
Electronic Journal: Oshikoya KA, Senbanjo IO, Njokanma OF and Soipe A. Use of complementary and alternative medicines for children with chronic health conditions in Lagos Nigeria [Online]. BMC Complementary and Alternative Medicine. Vol 88, article 66 (2008). Electronic Journal http://doi.org/10.1186/1472-6882-8-66 [Accessed: 23rd February 2017]
Web page: Focus on diarrhoea, dehydration and rehydration [online] www.rehydrate.org [Accessed: 29 May 2015]
General Style Points
The following points provide general advice on formatting and style:
Abbreviation–
This must be defined at first use, either in the text, in a figure or table, or in their associated legends. Please ensure that any abbreviations and all symbols used in equations are properly defined.
Numbers
Under 10 are spelled out, except for measurements with a unit (8mmol/l), age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
Units
SI units (mass or molar units) should be used. If other units are used, a conversion factor should be included in the Methods section.
Main Text: As all papers are subject to single-blind peer review, there is no need to anonymise your files.
ORCID: The corresponding author is required to add his/her ORCID ID when submitting the manuscripts.
Submission
The cover letter (along with the manuscript) should be submitted electronically to https://njcpt.com.ng/submit-manuscript-3/. If electronic submission on the website is not available for any reason, submission should be made via email attachment to submit@njcpt.com.ng with the name (or abbreviation) of the Journal and the phrase ‘Article Submission’ used in the subject line of the email.
Article Processing Charge Articles accepted for publication will attract a fee of Twenty Thousand Naira (N20,000.00) only for local authors.
Articles accepted from regional or international authors will attract a fee of One Hundred Dollars ($100.00).
Financial members of CPAN will pay 50% of the prescribed fees per location. It is the responsibility of the Editorial Board to prove financial membership.
Publication Process After Acceptance
Accepted Article Received in Production
The Editorial office will review the manuscript for compliance prior to peer review. As required, the Editorial office will communicate with the corresponding author on the status of the manuscript as it undergoes processing.
Proofs
Galley proofs of accepted articles will be sent to the corresponding author for final corrections before publication. The indicated corrections must be returned to the Editorial office within specified time frame.
Nigerian Journal of Clinical Pharmacy and Therapeutics
c/o Pharmacy House,
32, Faramobi Ajike Street,
Behind Idiroko Bus stop, Anthony,
Lagos, Nigeria.
Email: adm.njcpt@gmail.com
Call: +2349057889730, +2348059993533
The Editor-in-Chief,
Nigerian Journal of Clinical Pharmacy and Therapeutics
c/o Pharmacy
House, 32, Faramobi Ajike Street,
Anthony Village, Behind Idiroko Bus Top, Anthony
Lagos, Nigeria